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AbSTrAcT
ObjEcTIvE: To examine the association between thyroid profile and morbidity/mortality (MM) 
in hospitalized older patients. DESIGN: This is a retrospective study of patients over the age of 
60yr admitted to the Dr. cesar Milstein Hospital between 2009 and 2010 and who had thyroid 
function tests (TFT). The patients were grouped as per their thyroid tests and their clinical 
characteristics and MM was associated with their TFT. High MM was defined as mortality, 
intensive care unit (Icu) requirement or prolonged hospital stay (>18 days, 75th percentile), 
and mortality assessed during an 18-month follow-up period after their hospital discharge. 
rESulTS: Out of 2599 older patients admitted to our hospital, 7% had TFT performed for 
various reasons. The patients who had TFT were mostly women and presented in a more seri-
ous clinical condition compared to the rest of the patients. The patients were grouped as per 
their thyroid values as follows: 61% of them had a non-thyroidal illness, 25% were euthyroid, 
7% had overt hyperthyroidism, 5% overt hypothyroidism and 1% had subclinical hyper- or 
hypothyroidism. The hypothyroid patients had a worse clinical outcome compared to the oth-
ers. Patients with increased MM exhibited higher TSH and lower TT4 (p<0.005). Short-term 
MM (Or=2.0,95%cI=1.1-3.6, p<0.01) was associated with the decrease of TT4 adjusted by 
age, sex, T3 and TSH, while for long-term MM the increase in TSH (Or=1.6,95%cI 1.1-2.3, 
p<0.05) was also significant. cONcluSION: Among hospitalized older patients who had TFT 
tests, low TT4 and high TSH were associated with a worse prognosis. We propose that TFT be 
used as an additional tool in assessing MM in elderly hospitalized patients. 
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IntRoductIon
Thyroid hormones change with age. In old age, 
serum triiodothyronine (T3) levels tend to decrease, 
while tetraiodothyronine (T4) values remain un-
changed.1 With regard to thyrotropin (TSH) levels, 
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the literature is controversial. According to some 
authors, TSH values may be lower in older adults than 
in the whole population.2 However, it has recently 
been reported that aging shifts the TSH distribu-
tion curve and the 97.5th percentile to higher TSH 
concentrations.3 All these alterations create a major 
disadvantage for the correct interpretation of thyroid 
status in the elderly.
With regard to hospital older patients, the preva-
lence of thyroid laboratory tests abnormalities, even 
without previous thyroid disease, is quite high. While 
the diagnosis of hypothyroidism has been reported 
in about 2% of this population,4 non-thyroidal illness 
(NTI), also known as euthyroid sick syndrome, is the 
main finding.5 The laboratory parameters of NTI 
usually include low serum levels of T3 and normal 
or low serum levels of T4 and TSH. Iglesias et al.5 
reported that out of 447 elderly hospitalized patients, 
332 (74.3%) had some kind of alteration of TSH and/
or thyroid hormones. This last group was mainly rep-
resented by NTI (n:278, 62.2%). In contrast, Tognini 
et al,6 excluding patients requiring intensive care unit 
facilities, found only 31.9% of 301 hospitalized older 
adults with this syndrome. Although higher hospital 
mortality has been linked to NTI,5,6 it is still unclear 
whether it is involved in the progression of disease 
or simply represents a marker of worse outcome for 
patients during hospitalization.7 On the other hand, 
the impact of true hypothyroidism present in a criti-
cally ill patients has not been explored, speculation 
being that in the elderly it might even be protective.8
While alterations of thyroid function in hospitalized 
elderly patients are very frequent, routine testing is not 
at present recommended.4,9 Unless there is a specific 
clinical reason for suspecting that thyroid dysfunction 
may be contributing to the clinical condition, thyroid 
diagnostic tests should be delayed until the resolution 
of the disease. If primary hypothyroidism has been 
ruled out, higher TSH levels rather than lower serum 
T4 levels are more reliable for diagnosis.10
The aim of the present study was to define the 
characteristics of those older patients in whom thyroid 
function testing (TFT) was requested during hospi-
talization, and secondly, to analyze the possible as-
sociation between hospital morbidity/mortality (MM) 
and thyroid abnormalities present in these patients.
methods
Population
This is a retrospective study conducted in a Hos-
pital for the elderly in Buenos Aires over a 6-month 
period, from August 2009 to January 2010. Out of the 
2599 patients aged 60yr or older who were admitted 
to our institution, 180 had their TFT measured for 
a variety of reasons. The clinical notes were recalled 
from the computer system of the laboratories. Clinical 
characteristics of this group (TFT) were compared 
with the whole population and also with a selected 
group (control) of admitted patients without TFT 
matched for gender, age and reason for admission. 
All patients signed informed consent to participate 
in the study and the study protocol was approved 
by the Ethics Committee of the Dr. Cesar Milstein 
Assistance Unit.
The specific clinical indications for TFT were 
identified and the patients were classified according 
to thyroid hormones and thyrotropin (TSH) values 
into different categories: euthyroidism (Eu), non-
thyroidal illness (NTI), subclinical (SH) and overt 
hyperthyroidism (OH); and subclinical (sh) and 
overt hypothyroidism (oh). The current treatment 
of every patient included in the study was recorded. 
High MM was defined as a composite endpoint of 
mortality, intensive care unit (ICU) requirement or 
prolonged hospital stay (>18 days, 75th percentile). 
Long-term MM was defined with the addition of the 
data concerning mortality at 18 months after discharge.
Hormonal assays
In 68% and 80% of the cases, serum samples were 
obtained before day 5 and 10 of admission, respec-
tively. Every extraction was done between 8:00 and 
9:00 am. Samples were assayed using an automated 
assay system (Immulite 1000, Siemens Medical So-
lutions Diagnostics, Los Angeles, CA, USA). The 
methodologies used for the different hormones were: 
TSH: two-step immunometric assay, and TT4 and T3 
competitive immunoassay. The intra-assay and inter-
assay coefficients of variation (CVs) were: TSH= 
1.6 and 7.6 %, TT4= 3.2 and 9.1% and T3= 3.3 and 
7.6%. Reference values: TSH 0.3-5 mU/l, TT4 4.5-13 
μg/dl, T3 0.8-1.9 ng/dl. 
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(5%), use of amiodarone (3%), anasarca edema 
and ascites (3%), goiter (3%), weight loss (1.5%) 
and scheduled thyroidectomy (1.5%). Most TFT 
were ordered by the Internal Medicine Department 
(62%) followed by Cardiology (18%), Neurology 
(10%) and Endocrinology (4%). In 6% of patients 
we were not able to determine which Department 
had made the order.
As in 80 out of the 180 cases the medical records 
were judged incomplete, the TFT patients group 
finally included only 100 subjects whose clinical 
characteristics and outcome were first compared to 
that of the entire population (n=2419). Patients with 
TFT presented a higher prevalence of female gender 
(70 vs. 58%, p<0.05) and an older age (75 (70-82) 
vs. 73 (67-80) years, respectively; p<0.0001) than the 
others. In addition, they were more severely ill as evi-
denced by a longer hospital stay (8 (5-18) vs. 2 (1-6) 
days, p<0.0001), and higher ICU requirement (13 vs. 
5%, p<0.0001) and mortality (15 vs. 4%, p<0.0001). 
Considering these differences, TFT patients were 
compared to an age-, gender- and reason for admis-
sion-matched group of in-patients from the total 
cohort (control patients, n=100). Clinical outcome 
for TFT and control patients is shown in Figure 1. 
While no significant differences were observed as to 
hospital stay and mortality, TFT patients still presented 
a more deteriorated health condition as evidenced 
by a higher requirement for ICU hospitalization and 
also higher MM.
TFT patients were subsequently classified accord-
ing to TSH and thyroid hormone levels. Sixty-one 
percent of the patients were included as NTI, 25% 
as Eu, 7% as SH, 5% as oh and 1% as both sh and 
OH. Age was not different among groups. TFT mean 
values for each thyroid status category are depicted 
in Table 1. Considering the clinical indication for 
TFT, we found that of all the patients with hypo-
natremia, only 5.5% had oh, with arrhythmia and 
cardiopathies, 15% were SH, and out of all patients 
in whom TFT was requested because there was a 
history of hypothyroidism, 23% were actually found 
oh. Twenty-nine percent of TFT patients had hypo-
thyroidism diagnosed prior to admission and were 
receiving levothyroxine. Only 4% of patients had a 
history of previous hyperthyroidism. 
Criteria for diagnosis
Overt hyperthyroidism was diagnosed when TT4 
was over 13 μg/dl and/or T3 over 1.9 ng/dl and TSH 
below 0.3 mU/l. Subclinical hyperthyroidism was 
diagnosed when TT4 (4.5-13 μg/dl) and T3 (0.8-1.9 
ng/dl) were normal and TSH below 0.3 mU/l. Eu-
thyroidism was diagnosed when all hormones were 
within their normal range: TSH 0.3-5 mU/l, TT4 4.5-
13 μg/dl, and T3 0.8-1.9 ng/dl. Overt hypothyroidism 
was diagnosed when TT4 was below 4.5 μg/dl and 
TSH over 5 mU/l. Subclinical hypothyroidism was 
diagnosed with normal levels of TT4 4.5-13 μg/dl 
and T3 0.8-1.9 ng/dl with TSH over 5 mU/l. NTI was 
diagnosed when T3 levels were below 0.8 ng/dl and 
the rest of the hormones within their normal range 
or in any case where the combination of hormones 
would not fit in the previous categorization.
Statistical analysis
Data were expressed as mean and standard de-
viation or median and interquartile range (IQR) as 
appropriate. Mann-Whitney and Kruskall Wallis tests 
were used to compare data between two and among 
multiple groups, respectively. The Fisher test was 
used to compare proportions between two groups, 
and when more than two were compared a Z-test 
with the Bonferroni method for multiple comparisons 
was employed. Associations among hormone levels 
and in-hospital and long-term morbimortality were 
evaluated by multiple logistic regressions. Potential 
confounders/predictors that were tried in the multi-
ple logistic regression as covariates include: gender, 
drugs, loge-transformed TSH concentration and the 
standardized concentration of TT4 and T3 levels. 
p<0.05 was used to consider statistical significance. 
SPSS ® 17.0 software (Chicago, Ill) was used in all 
statistical analyses.
Results
Clinical characteristics of TFT patients
Out of the 2599 patients admitted to our Hospital 
180 (7%) had TFT. In our Institution TFT are not 
prescribed routinely. Indications to measure TFT 
were the following: hyponatremia (30%), cardiologic 
evaluation (21.6%), previous history of thyroid illness 
(21.6%), clinical hyperthyroidism (6.6%), anemia 
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Association of thyroid status with clinical 
outcome and morbimortality in TFT patients
The clinical outcome of TFT patients within each 
thyroid status category was analyzed and significant 
differences were found among groups. Hypothyroid 
(oh and sh) and NTI patients presented a statistically 
significantly longer hospital stay than the Eu and 
hyperthyroid (OH and SH) patients (hypothyroid: 
28[19-40], NTI: 11 [6-18], Eu: 6 [3-11] and hyperthy-
roid: 4 [2-11] days, p<0.01 for hypothyroid against 
all other patient categories and for NTI against Eu 
and hyperthyroid patients). Moreover, the hypothy-
roid patients presented the highest prevalence of 
ICU requirement (hypothyroid: 83%, NTI: 25%, 
Eu: 22% and hyperthyroid: 13%, p<0.05), and of 
mortality (hypothyroid: 50%, NTI: 10%, Eu: 10%, 
and hyperthyroid: 0%, p>0.05), though the latter did 
not attain statistical significance.
Furthermore, when TSH and thyroid hormone 
concentrations were compared within TFT patients 
classified according to MM, the high MM patients vs 
the low MM were characterized by higher TSH (2.5 
[0.9-6.4] vs. 1.3 [0.8-2.6] mU/l, respectively, p<0.05) 
and lower TT4 concentration (6.9 ±2.4 vs. 8.3±2.0 μg/
dl, p<0.005), while no difference was observed in T3 
plasma levels (0.71±0.34 vs. 0.79±0.35 ng/dl, p>0.05). 
Accordingly, by multiple logistic regression the 
decrease of TT4 was the only TFT associated with 
higher short-term MM (Table 2) adjusted by age, 
gender, T3 and TSH concentration. However, when 
long-term MM was analyzed employing the same 
model, the increase in TSH concentration also at-
tained statistical significance (Table 3). 
Figure 1. Clinical outcome of TFT and control patients. ICU 
req., intensive care unit requirement; MM, morbimortality. Ev-
ery bar shows the percentage of patients, with the exception of 
hospital stay in which the bars stand for days. a = p<0.0001; b 
= p<0.01. 
Table 1. TSH and thyroid hormones concentration from TFT patients 








Total (n=100) 1.7 (0.9-3.2) 7.7 ± 2.2 0.76 ± 0.34
OH (n=1) 0.2 (NA) 11 ± NA 0.98 ± NA
SH (n=7) 0.2 (0.04-0.3) 7.7 ± 2.2 1.07±0.15
Eu (n=25) 1.5 (1.0-2.5) 8.6 ± 1.9 1.08±0.26
oh (n=5) 8.8 (6.8-20.8) 4.16±0.68 0.49±0.21
sh (n=1) 8.6 (NA) 6.2 ± NA 1.1 ± NA
NTI (n=61) 1.7 (0.9-3.5) 7.54±2.24 0.61±0.28
OH and SH: overt and subclinical hyperthyroidism; oh and sh: 
overt and subclinical hypothyroidism; Eu: euthyroid; NTI: non-
thyroidal illness; n: number of patients; NA: not available; SD: 
standard deviation.
Table 2. Multiple logistic regression analysis of variables associated 
with high morbidity/mortality (MM) in TFT patients 
 Or (cI 95%) p
Gender 1.3 (0.5-3.5) 0.815
Age 1.0 (0.9-1.1) 0.579
Ln TSH 1.3 (0.9-1.9) 0.190
T3 (per 1-SD decrease) 0.9 (0.6-1.5) 0.727
TT4 (per 1-SD decrease) 2.0 (1.1-3.6) 0.019
SD: standard deviation. High MM was defined as a composite 
endpoint of mortality, intensive care unit requirement or pro-
longed hospital stay. T3-SD: 0.34 ng/dl and TT4-SD: 2.2 μg/dl.
Table 3. Multiple logistic regression analysis of variables associated 
with long-term morbimortality in TFT patients
 Or (cI 95%) p
Gender 1.7 (0.6-4.6) 0.476
Age 1.01 (0.96-1.06) 0.646
Ln TSH 1.6 (1.1-2.3) 0.020
T3 (per 1-SD decrease) 0.6 (0.4-1.0) 0.071
TT4 (per 1-SD decrease) 1.8 (1.1-3.2) 0.041
SD: standard deviation; Long-term MM was defined as high MM 
with the addition of the data concerning mortality at 18 months 
after being dismissed; T3-SD: 0.34 ng/dl and TT4-SD: 2.2 μg/dl.
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dIscussIon
The present study highlights the fact that among 
older patients with TFT measurement, only those 
who feature low TT4 levels or high TSH levels had a 
worse prognosis compared to our whole population. 
During prolonged critical illness, several tissue 
responses could be interpreted as compensatory to 
low thyroid hormone availability, although they might 
also be in fact reflecting a maladaptive response to 
stress.11 
In spite of the fact that the association between 
mortality and the decline of TT4 levels in critically ill 
patients is well recognized, the role of TSH levels in 
prediction of clinical outcomes still remains a matter of 
debate.12 Low levels of TSH are known to accompany 
NTI and also be a consequence of medication in sick 
patients.13,14 High levels of TSH, by contrast, found 
in ambulatory elderly subjects have been related to 
increased longevity.9 However, in critically ill elderly 
patients in whom thyroid disease is suspected, the 
prognostic value of higher TSH levels has not as yet 
been evaluated. In this context, it is worth mentioning 
our finding of a relationship between the progressive 
augment of a loge unit (from 1 to 2.1 mU/l, from 2.1 
to 7.4 mU/l, and so on) of TSH concentration with a 
higher risk for a worse clinical outcome in the TFT 
group. Specifically, increasing levels of TSH were 
associated with a 1.3 and a 1.6-fold rise in the risk of 
short- and long-term MM, respectively, being only 
statistically significant for long-term MM. Further-
more, the results from the present study agree with 
previous ones confirming the influence of low TT4 
levels over MM,12,13 as the progressive decrease in 
2.2 μg/dl of TT4 concentration (1SD unit) was asso-
ciated with a 2.0 and 1.8-fold increase in the risk of 
short- and long-term MM, respectively. With regard 
to the possible effect of medication on our results, 
several drugs were considered as confounders in the 
multivariate logistic regression. However, since the 
effects on short- and long-term MM were for every 
drug non-significant (including corticosteroids, le-
vothyroxine, etc), and the T4 and TSH association 
remained unaffected by its inclusion, the statistical 
analyses were carried out excluding drug treatments.
An entire body of literature4-9 has been devoted 
to the difficulties in clearly differentiating between 
hypothyroidism and NTI in hospitalized patients, and 
our study forms no exception. Judging by the low T3 
and T4 values with moderately elevated TSH values 
found in the overt hypothyroid group, it might be 
inferred that the worse outcome observed in these 
patients could be explained by the presence of NTI 
superimposed in a preexisting hypothyroid condition. 
However, in contrast to NTI, in which high TSH levels 
reflect recovery of the disease,7 our patients with high 
TSH levels presented a worse clinical course. Although 
patient-misclassification might be biasing these results, 
and increased TSH may be simply the result of the 
acute illness, the use of the thyroid hormones levels 
as continuous variables in the logistic regression 
models, instead of thyroid function categories that 
imply the choice of specific cut-off values, tended to 
minimize any misinterpretation of the results. In fact, 
the association between worse prognosis and high 
TSH levels found in the present study agrees with 
what has been recently reported by Iglesias et al.15 In 
this study the authors established that higher serum 
TSH values in elderly patients found at the beginning 
of hospitalization were related to a thyroid profile 
of persistent NTI, while the lowest TSH values were 
associated with recovery of thyroid function after one 
month of discharge. Furthermore, in our study most 
TSH values were assessed at the beginning of their 
hospitalization, while high TSH levels in the context 
of NTI have been described once the patient has 
succeeded in recovering from disease.7 Considering 
also that the TFT group had a very high proportion of 
previously hypothyroid patients, it is possible that the 
worse prognosis associated with increased TSH levels 
might in reality reflect the impact of the lack of thyroid 
hormones in the tissues. Therefore, the cause of the 
high mortality in patients having higher TSH values 
could be explained by the well recognized detrimental 
effects of hypothyroidism, such as increased systemic 
vascular resistance, decreased cardiac contractility, 
decreased cardiac output and accelerated atheroscle-
rosis and coronary artery disease.16 We acknowledge, 
though, that ATPO or thyroid ultrasound assessment 
would have proved useful to confirm hypothyroidism; 
however, due to the retrospective nature of the study 
this was not possible. 
While there is controversy as to the frequency of 
NTI in hospitalized older patients,5,6 our findings agree 
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with what had been previously reported by Iglesias et 
al.5 However, unlike these authors, we found a higher 
proportion of hypothyroidism and hyperthyroidism. 
This may be explained by the design of our case finding 
study. Surprisingly, most patients in the oh category 
had a history of hypothyroidism and were currently 
on levothyroxine. The observation of increased le-
vothyroxine requirements in hypothyroid critically 
ill patients has recently been reported by Imberti et 
al.17 A possible explanation for our findings may be 
that the drug was probably interrupted at admission 
to the hospital or that it was malabsorbed during the 
patient’s stay. On the other hand, and in agreement 
with the literature,18 almost one third of the patients 
classified as SH were on supraphysiological doses of 
levothyroxine. 
The lack of association between low T3 levels and 
worse clinical outcome was unexpected. However, 
when analyzing TFT patients characteristics, the 
T3 levels were indeed low normal on our reference 
scale. In effect, 75% of the population exhibited T3 
concentrations ranging between 0.46-0.89 ng/dl. This 
feature might account for the lack of association 
between T3 levels and MM. 
In conclusion, in older patients with TFT, whether 
NTI or hypothyroid, low TT4 or high TSH were as-
sociated with higher short- and long-term MM. The 
increased morbid-mortality in older patients found to 
be hypothyroid in the context of acute illness and the 
exact role of high TSH levels necessitate further study. 
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